This report contains market size and forecasts of Preimplantation Genetics Diagnosis (PGD) in Global, including the following market information:
Global Preimplantation Genetics Diagnosis (PGD) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Preimplantation Genetics Diagnosis (PGD) market was valued at 99.8 million in 2021 and is projected to reach US$ 125.7 million by 2028, at a CAGR of 3.3% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Gender Selection Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Preimplantation Genetics Diagnosis (PGD) include Abbott Laboratories, Natera, Inc, PerkinElmer, Illumina, F. Hoffmann-La Roche, Thermo Fisher Scientific, Laboratory Corporation of America Holdings, Agilent Technologies and Quest Diagnostics Incorporated, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Preimplantation Genetics Diagnosis (PGD) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Preimplantation Genetics Diagnosis (PGD) Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Preimplantation Genetics Diagnosis (PGD) Market Segment Percentages, by Type, 2021 (%)
Gender Selection
Chromosomal Abnormalities
Single Gene Disorders
HLA Typing
Aneuploidy
X-Linked Diseases
Others
Global Preimplantation Genetics Diagnosis (PGD) Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Preimplantation Genetics Diagnosis (PGD) Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Others
Global Preimplantation Genetics Diagnosis (PGD) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Preimplantation Genetics Diagnosis (PGD) Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Preimplantation Genetics Diagnosis (PGD) revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Preimplantation Genetics Diagnosis (PGD) revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott Laboratories
Natera, Inc
PerkinElmer
Illumina
F. Hoffmann-La Roche
Thermo Fisher Scientific
Laboratory Corporation of America Holdings
Agilent Technologies
Quest Diagnostics Incorporated
Cooper Surgical
Beijing Genomics Institute (BGI)
Genea Limited